May 1, 2008

Nation’s largest technology association recognizes top Southern California innovators at the AeA 15th Annual High-Tech Innovation Award Winners -

Jan 2, 2008

Morgenthaler Ventures Media Roundtable Event to Feature Symphony Medical -Novel Heart Failure Technology to be Presented to Journalists from Wall St Journal, NY Times, Business Week, Dow Jones and others

Jan 2, 2008

Symphony Medical to Present at OneMedPlace Emerging Healthcare Technologies Finance Forum - Jan 8, 2008 -

Aug 18, 2007

Symphony Medical Completes Expansion of its Senior Management Team -Sam L. Helgerson, Ph.D, Bob Peterson and Rena S. Juliar Join the Team

Jul 5, 2006

Symphony Medical Announces Initiation of Phase II Multi-Center Clinical Trial for Biologic Therapy to Prevent Post-Operative Atrial Fibrillation -Study Intended to Validate Efficacy and Move Novel Technology Closer to Commercialization

May 31, 2006

Symphony Medical Inc. Names Raymond W. Cohen as Chief Executive Officer -Former Cardiac Science CEO Has Over 25 Years of Leadership, Entrepreneurial Experience in Healthcare

May 17, 2006

Temporary modification of the epicardial fat pads in patients undergoing low to moderate risk open heart surgery -Safety and efficacy of a novel approach for lowering the incidence of post operative atrial fibrillation

May 17, 2006

Autologous Dermal Fibroblasts slow atrioventricular conduction when injected in the perinodal region -Nassir F. Marrouche, MD, Anno Diegler, MD, Klaus Gutleben, MD, Guido Ritscher, MD, Jens Günther, MD, Anil Sinah, MD, Kai Kögler, MD, Petra Denninger, RN, Ute Göbel, RN, Andrea Höhn, MD and Johannes Brachmann, MD. University of Utah, Salt Lake City, UT, He